biotech firesales Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	6/2/2005 5:59:47 AM
	Read Replies (1) of 3661

Elan, again.... Elan falls on new report of Tysabri-linked illness Thu Jun 2, 2005 05:40 AM ET DUBLIN, June 2 (Reuters) - Shares in Elan Corp. (ELN.I: Quote, Profile, Research) fell as much as 24 percent on Thursday following a report that a fourth patient taking its multiple sclerosis drug Tysabri may have contracted a deadly brain disease. Elan halted sales of Tysabri on February 28 after a patient died from a rare brain infection, known as PML. Two further cases were later identified. The Boston Globe reported on Thursday that Biogen Idec Inc., with whom Elan developed the treatment, had told the U.S. Food and Drug Administration (FDA) a fourth patient may have contracted PML...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next